Physical Activity Assessment of Patients With Diabetic Foot Wounds
NCT ID: NCT04582357
Last Updated: 2022-10-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2020-12-31
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study will aslo evaluate the security of this program, and how it could improve or not the quality of life, the diabet's metabolical balance, and the wounds's cicatrization speed.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Feasibility and Acceptability of Non Weight-bearing Physical Activity for People With Diabetic Foot Ulceration
NCT06092827
Effects of a Exercise Program on Health Outcomes in People With Diabetic Foot Ulcers
NCT03002155
Exercise Enhances Wound Healing in Patients With Diabetic Foot Ulcers
NCT04791449
The Effect of Exercise on Wound Healing While Off-loading
NCT04280016
RCT Comparing Upper Body vs. Combined Exercise Protocols During Active Diabetic Foot Ulcer Treatment
NCT06916663
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The study will last 6 months, the inclusion will last 3 months, and each patient will have a 3 months follow-up time. The patient have several medical appointments in the diabetic foot unit, where the compliance will be evaluated, wound size and security will also be evaluated.
The activity program is a suite of exercises, 4 times in a week, it lasts 30 minutes?
The first day, follow-up book is given to the patient. During the follow-up, the patient will still have his usual medical appointments, which will occur at the 30th, 60th and 90th days.
Phone-call appointments will also be possible at the 15th and 45th days.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Exercise arm
This arm is the only arm of the study, every patient is included in this arm, the patients will follow the physical activity program
Physical activity program
The physical activity program is a suite of several exercises which intend to improve muscular mass of targeted muscles.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Physical activity program
The physical activity program is a suite of several exercises which intend to improve muscular mass of targeted muscles.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Every patient over 18 years old
* Diabet whatever the type, with foot wound, whatever the size, or duration.
Exclusion Criteria
* Administrative cause : impossibility to provide written informed consent, impossibility to be followed up during the needed duration, no medical insurance, rejection to sign the consent paper.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Lille
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Florence Baudoux, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Lille
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-A02274-35
Identifier Type: OTHER
Identifier Source: secondary_id
2019_67
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.